HealthResearchScience

Yale Researcher Devise drinkable cocktail for Alzheimer Therapy

drinkable Alzheimer cocktail

Yale researchers have fabricated a drinkable cocktail of designer mix that meddles with a pivotal initial step of Alzheimer’s and even reestablishes memories in mice, reported in Cell Reports.

 

The binding of amyloid beta peptides to prion proteins triggers a course of destruction measures in the advancement of Alzheimer’s — collection of plaques, a damaging immune system reaction, and harm to neural synapses.

 

"We needed to discover particles that may therapeutically affect this immune system response," said senior author Stephen Strittmatter, the Vincent Coates Professor of Neurology, professor of neuroscience, and director of the Yale Alzheimer Disease Research Center.

Reference:

Erik C. Gunther, et al., “Rescue of Transgenic Alzheimer’s Pathophysiology by Polymeric Cellular Prion Protein Antagonists,” Cell Reports, 2018; doi:10.1016/j.celrep.2018.12.021

Also Read

Novel Ebola Therapies: Health Workers at Risk at E... Ebola outbreak at Democratic Republic of Congo-2018 Health workers in Democratic Republic of Congo have started giving patients two trial medicatio...

Leave a Reply

Your email address will not be published.